laruparetigene zovaparvovec

News

Beacon is preparing to file for approval of its gene therapy for X-linked retinitis pigmentosa, after reporting encouraging phase 3 data.

News

Boehringer Ingelheim is paying $358m upfront for options on up to six antibody-drug conjugates and T cell engagers from China's Sino Biopharma.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.